Aspen Pharmacare Aust in
consultation with the Therapeutic
Goods Administration is
recalling one batch of its Imigran
(sumatriptan) cartridge injections.
A manufacturing fault led to
needles protruding through the
rubber needle shield in a small
percentage of the cartridge
injections in this batch.
The protruding needle will not
be sterile and affected cartridge
injections should not be used.
The affected batch number is
C632305 with an expiry date of
May 2015 - no other batches are
affected and no adverse events
have been reported as a result of
this fault.
Recently the UK’s Medicines
and Healthcare products
Regulatory Agency (MHRA) alerted
pharmacies, dispensing clinics and
wholesalers to return stocks of the
Imigran injectable for the same
fault (PD 13 Oct).The above article was sent to subscribers in Pharmacy Daily's issue from 13 Nov 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Nov 13
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
A NEW study from the University of South Australia has discovered that an increased cardio-fitness level will reduce risk of death from any cause by nearly 20%.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.